During the first year of life , intermittent SP treatment reduced the incidence of clinical malaria by 22.2 % ( 95 % confidence interval [ CI ] , 3.7 % -37.0 % ; P = .020 ) and the rate of hospital admissions by 19 % ( 95 % CI , 4.0 % -31.0 % ; P = .014 ) .
